Shaily Engineering Secures Significant Order Win, Boosting Investor Interest

Shaily Engineering, a small-cap stock with a market capitalization of ₹8,921 crore, is expected to attract investors' attention during Thursday's session, February 26, following the company's significant order win.

Order Details The company has secured a contract with a large domestic pharma company for the supply of pen injectors over a period of four years, valued at ₹423 crore. The customer's name has not been disclosed due to confidentiality reasons, and the company has clarified that the order does not fall under related-party transactions.

Recent Performance In its Q3 results 2026, Shaily Engineering reported a consolidated net profit of ₹37 crore, compared to ₹25 crore in the same period last year. However, on a sequential basis, net profit declined by 27.45%. Revenue from operations during the reporting quarter came in at ₹250 crore, compared to ₹198 crore in the same period last year.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Key Highlights

• Revenue from the healthcare division improved by 139% year-on-year to ₹104.3 crore.
• EBITDA improved by 43% year-on-year to ₹66.4 crore, while margins expanded by 310 basis points year-on-year to 26.5%.

Stock Performance Shaily Engineering shares have been under pressure since the start of the year, losing significant value. The stock closed January with a decline of 15.4%, marking its second consecutive monthly drop. At the current trading price of ₹1,941, the stock is down 31% from its record high of ₹2,799 per share. Despite the sharp pullback, the stock's long-term gains remain intact, as it still trades 789% higher over the last three years and 360% higher over the past five years.